Complications of Polyacrylamide Hydrogel
PDF | The use of Polyacrylamide hydrogel (PAAG) as an injectable filler for breast augmentation has fallen out of popularity since its first use in the... | Find, read and cite all the research
Polyacrylamide hydrogel (PAHG) is a medical soft tissue filling agent utilized for the treatment of a variety of soft tissue defects. However, postoperative complications occur that have to be alleviated. The aim of the present study was to examine the treatments of postoperative complications of mammoplasty augmentation with PAHG.
Complications of polyacrylamide gel filler in the Asian
Download Citation | Complications of polyacrylamide gel filler in the Asian-Australian population | Polyacrylamide gel (PAAG), known as Aquamid® (Contura Limited, London, United Kingdom, EC4A 1LB
Type: Case series Published: 15-03-2025 Complications of polyacrylamide gel filler in Asian-Australians: a case series. Amanda Yang Shen MBBS, 1 Frank Lin MBBS FRACS (Plas) 2
Complications and Radiologic Features of Breast
That filler has been widely used for interstitial mammoplasty for 10 years, especially in Asian countries. 6 However, the use of polyacrylamide gel was banned in 2006 because there have been numerous reports that it results in adverse complications such as localized lumps, deformities, infections, gel migration, and even loss of the ability to
The polyacrylamide gel (PAAG) is a permanent filler material used worldwide. In spite of the fact that the filler materials used today are considered quite safe, various complications have been
Treatment of complications from polyacrylamide hydrogel
Discussion. Hydrophilic polyacrylamide hydrogel, or HPAMG, is broadly used as an injectant in breast augmentation due to its relatively good physiological compatibility and steady physicochemical property ().However, the complications of surgery leads to the patient experiencing pain.
A middle-aged Chinese woman, who in her younger years had her breasts enlarged via polyacrylamide hydrogel injections, recently found that her injected breast implants have “dropped” all the
Cryptococcus gattii Infections - PubMed Central (PMC)
SUMMARY. Understanding of the taxonomy and phylogeny of Cryptococcus gattii has been advanced by modern molecular techniques.C. gattii probably diverged from Cryptococcus neoformans between 16 million and 160 million years ago, depending on the dating methods applied, and maintains diversity by recombining in nature. South America is the likely source of the virulent C. gattii VGII molecular
[23,24,25] Multiple studies have investigated the use of injectable facial filler agents for esthetic treatment of the facial volume loss caused by lipoatrophy; these filler agents included poly-L-lactic acid, calcium hydroxylapatite, hyaluronic acid, polyacrylamide gel, polyalkylimide gel, polymethylmethacrylate, silicone oil, and autologous
IMCAS - Dermatology & Plastic Surgery
IMCAS is dedicated to teaching of the highest quality at the interface of plastic surgery and dermatology. Our congresses take place four times a year in wonderful locations around the world. The content of each conference is shaped by the local aesthetic market of the host country, thus making each of our events unique.
AbstractThree kinds of acrylamide copolymers were synthesized in this paper, acrylamide (AM) homopolymer, acrylamide/acrylic acid (AA) copolymer and acrylamide/2-acrylamide-2-methylpropanesulfonic acid (AMPS) copolymer by free radical polymerization. The aggregation behaviours of these polymers in salts water solution were studied. The molecular chains of homopolymer were stretched in salt
- What is the global polyacrylamide market size?
- The global polyacrylamide market size was estimated at USD 5.5 billion in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2030.
- What is the value of polyacrylamide market in 2025?
- Polyacrylamide Market was valued at US$ 6.33 Bn. in 2025. Polyacrylamide Market size is expected to grow at a CAGR of 7.2% through the forecast period. Polyacrylamide is defined as an organic polymer extracted from the acrylamide subunit.
- How big is the cationic polyacrylamide market?
- The Cationic Polyacrylamide segment is also set to grow at 6.2% CAGR over the next 7 years. Regional Analysis: Gain insights into the U.S. market, estimated at $1.1 Billion in 2025, and China, forecasted to grow at an impressive 8.4% CAGR to reach $1.3 Billion by 2030.
- What is the market outlook for anionic polyacrylamide?
- This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Market Growth: Understand the significant growth trajectory of the Anionic Polyacrylamide segment, which is expected to reach US$2.7 Billion by 2030 with a CAGR of a 5.3%.
